Stellar Biotechnologies Presents at Annual 2013 NSF Conference
News Jul 05, 2013
Stellar Biotechnologies, Inc. has announced the presentation of a poster at the Annual 2013 National Science Foundation (NSF) Conference in Baltimore, MD highlighting the Company’s achievements in developing methods related to the sustainable cultivation of the ocean mollusk that is the sole source for Keyhole Limpet Hemocyanin (KLH).
KLH protein is only derived from the Giant Keyhole Limpet (Megathura crenulata), a scarce sea mollusk native to the Pacific Coast waters off California.
The poster titled “Megathura crenulata Post Larval Culture – Bottleneck for a Valuable Medical Resources” was presented by Brandon Lincicum, Stellar’s Executive Director of Aquaculture and Operations.
The presentation recapped innovations that have allowed Stellar to achieve, for the first time in the KLH industry, systems and processes that protect and sustain multiple generations of the Giant Keyhole Limpet in land-based aquaculture.
These accomplishments are critical to supplying enough clinical-quality KLH to meet the future demands of pharmaceutical companies and researchers.
Stellar’s work was partially supported by NSF SBIR Phase I/II, Phase IIB and prestigious Technology Enhancement Commercial Partnership (TECP) funding.
“Stellar now has the world’s only demonstrated aquaculture technology for sustainable growth and cultivation of Megathura crenulata and production of KLH,” said Lincicum. “It was gratifying to present our industry-leading accomplishments at the prestigious NSF conference.”
Inside cells, where DNA is packed tightly in the nucleus and rigid proteins keep intricate transport systems on track, some molecules can simply self-organize, find one another in crowded spaces, and quickly coalesce into droplets. Now, new research shows how proteins that organize into liquid droplets inside cells make certain biological functions possible.
About 422 million people around the world, including more than 30 million Americans, have diabetes. Obesity is the most significant risk factor for type 2 diabetes. yet about 30 percent of obese people do not develop type 2 diabetes or other metabolic conditions. New research aims to understand on a cellular level, how this separation occurs.READ MORE